StockTipsArenaBeta

BUY Aarti Drugs Limited — Somil Mehta, Sharekhan

BUYAarti Drugs Limited
Aarti Drugs share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via Zee Business (Live)

Entry₹445.05Inferred
Target₹550
Total upside +23.58% (call closed)
Stop loss₹395-11.25% risk
At expiry₹416.158 Oct 2026, 3:30 pm
Expired-6.49%
Follow Somil Mehta for new calls(26% target hit, 293 closed calls)Get alertsWatch AARTIDRUGS for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Oct 2026
1 supporting0 opposing
Supports the BUY call (1)

Pharma sector stocks gain today, September 23: Wockhardt jumps 3.93%, Aarti Drugs gains 3.57%, Natco Pharma rises 2.20%

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Drugs

All analyst calls on Aarti Drugs

More from Somil Mehta, Sharekhan

Every call and its outcome